2009年度诺贝尔化学奖授予了美国科学家Venkatraman Ramakrishnan、Thomas A. Steitz和以色列科学家Ada E. Yonath,以表彰他们"对核糖体结构和功能的研究"。高分辨率的核糖体晶体结构使得人们能够在原子水平深入精确地理解核...2009年度诺贝尔化学奖授予了美国科学家Venkatraman Ramakrishnan、Thomas A. Steitz和以色列科学家Ada E. Yonath,以表彰他们"对核糖体结构和功能的研究"。高分辨率的核糖体晶体结构使得人们能够在原子水平深入精确地理解核糖体的分子机制,并且为基于结构的合理化抗生素设计打下了坚实基础。以色列女科学家Ada E. Yonath是整个核糖体晶体结构研究领域的核心人物,她10多年坚持不懈地进行多种细菌核糖体的提纯与晶体生长工作,才使得核糖体高分辨率晶体结构解析成为可能。本文对2009年度诺贝尔化学奖的研究工作进行简要介绍。展开更多
Pseudomonas aeruginosa is an aerobic Gram-negative rod-shaped bacterium with a comparatively large genome and an impressive genetic capability allowing it to grow in a variety of environments and tolerate a wide range...Pseudomonas aeruginosa is an aerobic Gram-negative rod-shaped bacterium with a comparatively large genome and an impressive genetic capability allowing it to grow in a variety of environments and tolerate a wide range of physical conditions.This biological flexibility enables the P.aeruginosa to cause a broad range of infections in patients with serious underlying medical conditions,and to be a principal cause of health care associated infection worldwide.The clinical manifestations of P.aeruginosa include mostly health care associated infections and community-acquired infections.P.aeruginosa possesses an array of virulence factors that counteract host defence mechanisms.It can directly damage host tissue while utilizing high levels of intrinsic and acquired antimicrobial resistance mechanisms to counter most classes of antibiotics.P.aeruginosa co-regulates multiple resistance mechanisms by perpetually moving targets poses a significant therapeutic challenge.Thus,there is an urgent need for novel approaches in the development of anti-Pseudomonas agents.Here we review the principal infections caused by P.aeruginosa and we discuss novel therapeutic options to tackle antibiotic resistance and treatment of P.aeruginosa infections that may be further developed for clinical practice.展开更多
文摘2009年度诺贝尔化学奖授予了美国科学家Venkatraman Ramakrishnan、Thomas A. Steitz和以色列科学家Ada E. Yonath,以表彰他们"对核糖体结构和功能的研究"。高分辨率的核糖体晶体结构使得人们能够在原子水平深入精确地理解核糖体的分子机制,并且为基于结构的合理化抗生素设计打下了坚实基础。以色列女科学家Ada E. Yonath是整个核糖体晶体结构研究领域的核心人物,她10多年坚持不懈地进行多种细菌核糖体的提纯与晶体生长工作,才使得核糖体高分辨率晶体结构解析成为可能。本文对2009年度诺贝尔化学奖的研究工作进行简要介绍。
文摘Pseudomonas aeruginosa is an aerobic Gram-negative rod-shaped bacterium with a comparatively large genome and an impressive genetic capability allowing it to grow in a variety of environments and tolerate a wide range of physical conditions.This biological flexibility enables the P.aeruginosa to cause a broad range of infections in patients with serious underlying medical conditions,and to be a principal cause of health care associated infection worldwide.The clinical manifestations of P.aeruginosa include mostly health care associated infections and community-acquired infections.P.aeruginosa possesses an array of virulence factors that counteract host defence mechanisms.It can directly damage host tissue while utilizing high levels of intrinsic and acquired antimicrobial resistance mechanisms to counter most classes of antibiotics.P.aeruginosa co-regulates multiple resistance mechanisms by perpetually moving targets poses a significant therapeutic challenge.Thus,there is an urgent need for novel approaches in the development of anti-Pseudomonas agents.Here we review the principal infections caused by P.aeruginosa and we discuss novel therapeutic options to tackle antibiotic resistance and treatment of P.aeruginosa infections that may be further developed for clinical practice.
